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Control of membrane permeability is a key step in regulating the intracellular concentration of antibiotics. Efflux pumps confer
innate resistance to a wide range of toxic compounds such as antibiotics, dyes, detergents, and disinfectants in members of the
Enterobacteriaceae. The AcrAB-TolC efflux pump is involved in multidrug resistance in Enterobacter cloacae. However, the un-
derlying mechanism that regulates the system in this microorganism remains unknown. In Escherichia coli, the transcription of
acrAB is upregulated under global stress conditions by proteins such as MarA, SoxS, and Rob. In the present study, two clinical
isolates of E. cloacae, EcDC64 (a multidrug-resistant strain overexpressing the AcrAB-TolC efflux pump) and Jc194 (a strain
with a basal AcrAB-TolC expression level), were used to determine whether similar global stress responses operate in E. cloacae
and also to establish the molecular mechanisms underlying this response. A decrease in susceptibility to erythromycin, tetracy-
cline, telithromycin, ciprofloxacin, and chloramphenicol was observed in clinical isolate Jc194 and, to a lesser extent in EcDC64,
in the presence of salicylate, decanoate, tetracycline, and paraquat. Increased expression of the acrAB promoter in the presence
of the above-described conditions was observed by flow cytometry and reverse transcription-PCR, by using a reporter fusion
protein (green fluorescent protein). The expression level of the AcrAB promoter decreased in E. cloacae EcDC64 derivates defi-
cient in SoxS, RobA, and RamA. Accordingly, the expression level of the AcrAB promoter was higher in E. cloacae Jc194 strains
overproducing SoxS, RobA, and RamA. Overall, the data showed that SoxS, RobA, and RamA regulators were associated with the
upregulation of acrAB, thus conferring antimicrobial resistance as well as a stress response in E. cloacae. In summary, the regu-
latory proteins SoxS, RobA, and RamAwere cloned and sequenced for the first time in this species. The involvement of these pro-
teins in conferring antimicrobial resistance through upregulation of acrAB was demonstrated in E. cloacae.
Enterobacter cloacae is an important nosocomial pathogen re-sponsible for various infections, including sepsis, infections of
the respiratory tract and urinary tract, wound infections, and
meningitis. Multiple antibiotic-resistant strains have caused out-
breaks of infections in hospitals, usually in settingswhere seriously
ill patients are housed, such as intensive care units (ICUs). These
pathogens of concern in an ICU setting cause significant morbid-
ity and mortality, and infection management is complicated by
resistance to multiple antibiotics (44).
Efflux pumps confer innate resistance to a wide range of toxic
compounds, such as antibiotics, dyes, detergents, and disinfec-
tants in members of the family Enterobacteriaceae (35, 36). There-
fore, efflux pumps participate, at least partly, in the ability of bac-
teria to adapt to diverse environments, in drug resistance
mechanisms, and in bacterial pathogenesis.
Control of membrane permeability is a key step in regulating
the intracellular concentration of antibiotics in Enterobacteria-
ceae. The expression of porins and efflux pump components is
jointly controlled by several positive global regulators, which re-
spectively decrease or enhance transcription of specific genes such
as acrAB and tolC, directly or via a regulation cascade. The acrAB
regulationmechanismmust be examined to understand the phys-
iological role of AcrAB. In Escherichia coli, the expression of acrAB
may be subjected to multiple levels of regulation, and it is locally
modulated by the AcrR repressor (23). At a global level, AcrAB is
controlled by stressful conditions and by regulators such asMarA,
SoxS, and Rob (37, 40). In addition to identifying theMarA/SoxS/
Rob family, George et al. (13) also identified and characterized
RamA, a member of the AraC/XylS family, for its role in confer-
ring multidrug resistance (MDR) in Klebsiella. Most recently, the
ramA gene was identified in Enterobacter aerogenes, Enterobacter
cloacae, and Salmonella Typhimurium, in which it may also be
involved inMDR (9, 19, 52). These activators perform their func-
tion via binding to discrete but degenerate nucleotide sequences
known as the mar-, rob-, or soxbox sequences located in the up-
stream region of regulated genes (including acrAB) (14, 18, 25, 26,
30). The expression of each regulator is controlled differently. In
E. coli, the marA transcription is repressed by marR and dere-
pressed through binding by compounds such as salicylate (45).
The level of soxS is controlled by the activator soxR, in contrast to
the repressor activity of marR on marA. Activation of soxR by
superoxides and redox cycling compounds, such as paraquat, in-
duces expression of soxS and the subsequent induction of the
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soxRS regulon (11). Rob is an abundant protein that is expressed
constitutively (3), and its activity is enhanced by decanoate (40).
Regulation of ramA is provided locally by ramR, presumably
through prevention of RamR binding to an operator sequence
near ramA and the subsequent relaxation of RamR repression at
the ramA promoter (1, 38). Furthermore, induction of acrAB by
indole is regulated through RamA, independently of MarA, SoxS,
and Rob (30). The main goal of the present study was to inves-
tigate the regulation of acrAB, as well as its activator-encoding
genes soxS, robA, and ramA isolated from E. cloacae, in the
presence of different stress agents such as salicylate, decanoate,
tetracycline, and paraquat. In order to define this regulation
system, the effect of the inactivation or artificial overexpression
of soxS, robA, and ramA on the expression of acrAB and the
multidrug resistance phenotype of E. cloacae was also investi-
gated.
MATERIALS AND METHODS
Strains, culture media, and plasmids. The laboratory strains and plas-
mids used in the present study are listed in Table 1. The clinical isolates
used were two clonally unrelated strains of Enterobacter cloacae iso-
lated from two different patients: EcDC64 and Jc194 (33, 34). Both
strains were isolated from a patient admitted to the A Coruña Univer-
sity Hospital (Spain). Escherichia coli strain TG1 was used for cloning
procedures. All strains used in the study were maintained at80°C in 15%
(vol/vol) glyceroluntil use.The strainsweregrownonMacConkeyagarplates
(Becton Dickinson, Franklin Lakes, NJ), in Luria-Bertani (LB) broth, or on
LB agar in the presence of 50g of ampicillin/ml, 25g of kanamycin/ml, 30
g of chloramphenicol/ml, 4 g of gentamicin/ml, or 30 g of tetracycline/
ml,whennecessary.Salicylate (10mM),paraquat (100M),ordecanoate (10
mM) (all from Sigma-Aldrich, St. Louis, MO) were added to LB agar and
brothmedia, as required.
PCR amplification, sequencing, and cloning of soxS, robA, and
ramA efflux pump regulatory genes. Genomic DNA from EcDC64 was
extracted from overnight cultures at 37°C by use of a genomic DNA pu-
rification kit (Promega Corp., Madison, WI). The oligonucleotides used
to isolate, amplify, and clone the efflux pump regulatory genes are listed in
Table 2. To isolate and amplify soxS, robA, and ramA, oligonucleotides
were designed on the basis of the previously reported nucleotide sequence
of Enterobacter sp. strain 638 complete genome (GenBank accession code
CP000653). The upstream region of these genes was amplified by using
two consecutive random and specific primers. The partially random
primer arb.1F (5=-GGCCACGCGTCGACTAGTACNNNNNNNNNNA
CGCCC, where N represents A, T, G, or C) was used in the first PCR to
amplify anonymous fragments of DNA in the upstream region of the
regulator genes. PCR conditions consisted of 94°C for 3 min, followed by
5 cycles of 94°C for 30 s, 30°C for 30 s, and 72°C for 1 min, followed by 30
cycles of 94°C for 30 s, 45°C for 30 s, and 72°C for 1min, with a final 5-min
extension step at 72°C. The DNA fragments generated were then used as a
template for the second PCR in which the primer arb.2F (5=-GGCCACG
CGTCGACTAGTAC) was used. The reaction was performed under the
same conditions as the first PCR, except annealingwas carried out at 55°C.
The PCR product was purified from the gel, by use of a Geneclean kit (MP
Biomedicals, Ohio), and was then sequenced. Sequencing was carried out
with a Taq DyeDeoxi- terminator cycle sequencing kit in an automatic
DNA sequencer (377ABI Prism; Perkin-Elmer). Specific oligonucleotides
(Table 2) were designed from the sequences obtained to amplify each
regulator with its own promoter. Amplicons were then cloned into the
pCR-Blunt II-TOPO cloning vector, according to the manufacturer’s in-
structions (Invitrogen Corp., Carlsbad, CA), to generate the recombinant
plasmids named pTsoxS, pTrobA, and pTramA (Table 1).
Construction of knockout strains. Disruption of the soxS, robA, and
ramA genes in strain EcDC64 was performed by the method described by
Datsenko and Wanner (10), with some modifications. The Red helper
pKOBEG (kindly donated by J. M. Ghigo, Institut Pasteur, Paris, France)
TABLE 1 Bacterial strains and plasmids used in the present study
Strain or plasmid Features (resistance marker) Source or reference
Strains
E. cloacae
EcDC64 MDR phenotype strain overexpressing the AcrAB-TolC efflux pump 33, 34
Jc194 Clinical isolate with basal efflux pump expression and a more susceptible resistance profile than strain EcDC64 33, 34
EcsoxS::Km EcDC64 with the soxS gene disrupted with a kanamycin resistance marker This study
EcrobA::Km EcDC64 with the robA gene disrupted with a kanamycin resistance marker This study
EcramA::Km EcDC64 with the ramA gene disrupted with a kanamycin resistance marker This study
E. coli
BL21(DE3) E. coli cell suitable for transformation and protein purification Invitrogen
TG1 Susceptible E. coli strain used for cloning procedures Invitrogen
Plasmids
pACYC184 Cloning vector (chloramphenicol and tetracycline) 7, 39
pAcGFP1 Cloning vector (ampicillin) Clontech
pUCP24 Cloning vector (gentamicin) 50
pKOBEG Red helper plasmid (chloramphenicol) 8
pGFP pACYC184 (chloramphenicol) containing the acrAB promoter fused to the gene coding for GFP This study
pCR-BluntII-TOPO Cloning vector (kanamycin) Invitrogen
pTsoxS pCR-BluntII-TOPO (kanamycin) containing the soxS gene under the control of its own promoter This study
pTrobA pCR-BluntII-TOPO (kanamycin) containing the robA gene under the control of its own promoter This study
pTramA pCR-BluntII-TOPO (kanamycin) containing the ramA gene under the control of its own promoter This study
pUCsoxS pUCP24 (gentamicin) containing the soxS gene under the control of its own promoter This study
pUCrobA pUCP24 (gentamicin) containing the robA gene under the control of its own promoter This study
pUCramA pUCP24 (gentamicin) containing the ramA gene under the control of its own promoter This study
pGEM-t Cloning vector (ampicillin) Promega
pET-28 Expression vector (kanamycin) Novagen
pETM-44 Modified pET-24d expression vector (kanamycin) EMBL
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(Table 1) is a low-copy-number plasmid that contains a gene for chlor-
amphenicol resistance, a temperature-sensitive origin of replication, and
the Red system, which comprises an exonuclease and the  and  func-
tions of phage . The pKOBEG plasmid (Table 1) was introduced in the
strain EcDC64 by heat shock, and transformants were selected on LB agar
with chloramphenicol, after incubation for 24 h at 30°C. One transfor-
mant carrying the Red helper plasmid was made electrocompetent. A
selectable resistance gene was amplified by PCR from genomic DNA by
use of primers including 5= extensions with homology for the soxS, robA,
and ramA genes listed inTable 2. The PCRproductwas used to disrupt the
soxS, robA, and ramA genes of strain EcDC64 by electroporation. Electro-
poration (25 F, 200 , and 2.5 kV) of the electrocompetent strains was
carried out according to the manufacturer’s instructions (Bio-Rad Labo-
ratories, Madrid, Spain), with 50 l of a cell suspension and 1 g of the
purified and dialyzed PCR products. Dialysis was performed in order to
remove the salts of purified PCR products using 0.025-m-pore-size ni-
trocellulose membranes (Millipore, Billerica, MA). Shocked cells were
added to 1ml of LB broth, incubated overnight at 30°C, spread on LB agar
containing kanamycin, and incubated for 24 h at 30°C. Themutant strains
were then grown on LB agar containing kanamycin for 24 h at 44°C and
incubated overnight at 30°C on LB agar containing kanamycin and chlor-
amphenicol in order to test for the loss of the helper plasmid.
Construction of transcriptional reporter fusion. The oligonucleo-
tides listed in Table 2 were designed to amplify a fragment of 526 bp that
contained 506 bp upstream and 21 bp downstream of the ATG of the
acrAB operon from E. cloacae EcDC64. The PCR product was double
digested with BamHI and NcoI and fused to the gene encoding the green
fluorescent protein (GFP; acgfp1) in the pACGFP1 vector (Table 1). The
fragment containing the transcriptional fusionwas amplifiedwith specific
oligonucleotides (Table 2), purified and digested with HindIII and
BamHI, and then ligated with the T4 DNA ligase (Promega) into a simi-
larly digested pACYC184 expression vector to generate the recombinant
TABLE 2 Primers used in this study
Primer Genea Procedure Sequence (5=–3=)b
sox-F soxS* Cloning ATGTCNCATCAGCARATWATTCAG
sox-R soxS Cloning TTAGTTGAGCTGGTGGCGGTA
soxUp soxS Cloning CAGGGCCACCAGCGTGTGAATA
rob-F robA Cloning ATGGATCAGGCTGGAATTATT
rob-R robA Cloning TTAACGACGTACCGGAATCAG
robUp robA Cloning GGTGACGTTTTTAACGTCCGGATCG
ram-F ramA Cloning ATGATCAATCAGGAAGCTGA
ram-R ramA* Cloning TCAGTGSGYRCGRCTGTG
ramUp ramA Cloning TTGTGCTGGCGAAACATACC
soxSKmF soxS Knockout ACCATTTCGAATAGCCCGACTTCCTGGCGACCACATCAATGTTCAACGGCTGGTCGATAT
GTTCATCAATCCATTCAATACATATGAATATCCTCCTTAG
soxSKmR soxS Knockout AGTGCCCTTCCGGCAATACGCCGAACGCGTCGCCGATGGTGGCCAGAGGAATGCCGATAC
GTTGCGCAATTTTAATGATC TGTGTAGGCTGGAGCTGCTTCG
robAKmF robA Knockout GGCTATTCCAAGTGGCATCTGCAAAGGATGTTCAAGGATGTCACCGGTCATGCTATCGGT
GCCTATATTCGCGCACGTCGTGTGTAGGCTGGAGCTGCTTCG
robAKmR robA Knockout AACGCGCATCTGATGGCGGAACTCGGAGATCTGCTCCAGGGAGCAGGAGTAGCTCTGCGT
GGTGCCGACCAGGTGCGTTT CATATGAATATCCTCCTTAG
ramAKmF ramA Knockout CTACACCAGCCGTTACGCATCGAAGAAATTGCCCGCCACGCGGGTTACTCAAAATGGCAT
TTACAGCGGCTGTTTATGCA TGTGTAGGCTGGAGCTGCTTCG
ramAKmR ramA Knockout TGCGGGTAAACGTCTGCTGCGAGTCAAACCCGTAGCGCAGGCAGATGTCGTACACCCGCT
CGTCTGACTCACGCAGATCG CATATGAATATCCTCCTTAG
pacrA-F acrAB promoter Cloning TCAGCAACGAACTCACATTTATG
pacrA-R acrAB promoter Cloning TAACCCTCTGTTTTTGTTCATATGT
pacrAgfp-F pacrA::gfp construction Cloning CCAACGAACTCACATTTATG
pacrAgfp-F pacrA::gfp construction Cloning AGTCGCGGCCGCTCACTTGTACAGC
soxSpET44F soxS Cloning acatgtCGCATCAGCAAATTATTCAG
soxSpET44F soxS Cloning aagcttTTAGTTGAGCTGGTGGCGGT
ramApET44F ramA Cloning ccatggTCAATCAGGAAGCTGAAGGG
ramApET44R ramA Cloning aagcttTCAGTGCGCGCGGCTGTG
robApET28F robA Cloning catatgGATCAGGCTGGAATTAT
robApET28F robA Cloning ctcgagTTAACGACGTACCGGAATCA
acrA RT-F acrA RT-PCR GCCTCTGGCGGTCGTTCTGAT
acrA RT-R acrA RT-PCR AGAGGTTCGGATTTGAGCGTCAC
acrB RT-F acrB RT-PCR GTGAGCGTCGAGAAATCGTCCA
acrB RT-R acrB RT-PCR TACGGCTGATGGCGTCCTTCAT
rpoB RT-F rpoB* RT-PCR CAGCCGCGAYCAGGTTGACTACA
rpoB RT-R rpoB RT-PCR GACGCACCGCAGGATACCACCTG
soxS RT-F soxS RT-PCR GCGCAGGTTACTGCTGGCAGCG
soxS RT-R soxS RT-PCR GCGGCGAAACACGCGGGAAA
robA RT-F robA RT-PCR CGCGCGGCCCATTCTTGATA
robA RT-R robA RT-PCR GAGTGCCGGCGTCAACGAGA
ramA RT-F ramA RT-PCR CAAAGGCGAAAGTCTGGGGCG
ramA RT-R ramA RT-PCR CCCGTAGCGCAGGCAGATATCG
a *, The oligonucleotide degenerated where R is A or G,Y is C or T, S is C or G, W is T or A, and N is A, T, C, or G.
b Nucleotides shown in lowercase italics indicaterestriction sites for cloning.
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plasmid named pGFP (Table 1). Fusion was sequenced in order to verify
the DNA sequence.
Cloning procedures for complementation assays. Recombinant
plasmids were first constructed and then introduced in the knockout
strains for complementation studies. For construction of these plasmids,
universal primers M13 and M13Rv were used to amplify the soxS, robA,
and ramA genes under the control of their ownpromoter regions from the
pTsoxS, pTrobA, and pTramA recombinant vectors, respectively. The
amplified DNA was purified, digested, and then ligated with the T4 DNA
ligase (Promega) into the pUCP24 expression vector (Table 1), previously
digested with the same enzymes. The PCR fragments containing soxS and
ramA genes were cloned between BamHI and EcoRI sites, and the frag-
ment containing the robA gene was cloned between the HindIII and PstI
sites. The accuracy of the construct was checked by restriction analysis.
Antibiotic susceptibility testing. The susceptibility of various strains
to the following antibiotics was determined by the standard disk diffusion
method (Becton Dickinson) on Mueller-Hinton agar (Tables 3 and 4):
telithromycin, ciprofloxacin, erythromycin, chloramphenicol, and tetra-
cycline. The susceptibility to these antibiotics was also determined in the
presence of salicylate (10 mM), decanoate (10 mM), paraquat (100 M),
or tetracycline (the MICs for the strains tested were determined, after a
gradual, stepwise increase in the exposure to tetracycline) (Table 4).
Flow cytometry assays. To examine the effect of transcriptional reg-
ulators SoxS, RobA, and RamA on the multidrug efflux pump AcrAB-
TolC in E. cloacae, expression experiments were performed with GFP as a
reporter. Single colonies of each bacterial strain (harboring the pGFP
plasmid) were inoculated into 10 ml of LB broth containing appropriate
amounts of the selected antibiotics. After overnight incubation at 37°C
and 180 rpm, the cultureswere diluted 1:100 in LBmedium.The cells were
then incubated at 37°C with continuous shaking until they reached an
optical density at 600 nm (OD600) of 0.4 and were then diluted 1:100 in 2
ml of 0.9% saline solution. Induction experiments were performed to test
the effects of sodium salicylate (SAL), sodiumdecanoate (DEC), paraquat
(PQ), and tetracycline (TET) on acrAB expression. A 10 mM concentra-
tion of SAL, 10mMDEC, 0.1mMPQ, or theMICof TETwas added to the
cultures. Fluorescence analysis was performedwith a FACScan cytometer,
and 50,000 cells weremeasured for each sample. The values obtainedwere
calculated as fluorescence units relative to the control strain containing
the reporter plasmid grown under the same conditions.
Real-time RT-PCR experiments. Real-time reverse transcription-
PCR (RT-PCR) was carried out to determine the expression levels of the
soxS, ramA, and robA regulator genes and the efflux components acrA and
acrB. Specific primers designed from soxS, ramA, robA, acrA, and acrB
sequences (GenBank accession code JQ727666 for soxS gene; JQ727667
TABLE 3 Antibiotic susceptibility profilesa
Strain and stimulus
Antibiotic susceptibility (inhibition zone diam [mm])
Erythromycin Tetracycline Telithromycin Ciprofloxacin Chloramphenicol
Jc194
None 10 25 13 34 24
SAL 0 18 9 28 21
DEC 0 23 11 32 24
PQ 0 18 8 27 17
TET 0 11 8 27 11
EcDC64
None 0 0 9 32 25
SAL 0 0 0 28 21
DEC 0 0 8 32 25
PQ 0 0 0 27 18
TET 0 0 0 32 24
EcrobA
None 10 26 14 38 24
SAL 0 21 11 28 22
DEC 10 26 13 46 33
PQ 0 18 11 27 17
TET 0 14 10 26 16
EcsoxS
None 9 23 14 34 24
SAL 0 18 11 29 25
DEC 8 22 12 32 25
PQb 10 31 17 42 28
TET 0 16 11 29 15
EcramA
None 10 25 15 37 25
SAL 0 19 12 28 23
DEC 9 22 12 31 27
PQ 0 18 12 32 18
TET 0 24 17 40 26
a Antibiotic susceptibility profiles, expressed as the diameters of the inhibition zones, were determined by the standard disk diffusion method for the bacterial isolates in the
presence of various stimuli: 10 mM sodium salicylate (SAL), 10 mM sodium decanoate (DEC), 0.1 mM paraquat (PQ), or 4 g of tetracycline/ml (TET). A value of “0” means that
an inhibition zone around the disk (6 mm) was not detected.
b The concentration of paraquat used was 50 M.
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for robA gene and JQ727668 for ramA gene) are listed in Table 2. Total
RNAwas isolated with a High-Pure RNA isolation kit (Roche Diagnostics
GmbH, Mannheim, Germany) according to the manufacturer’s instruc-
tions. The concentration of RNAwas determined spectrophotometrically.
RNA (1g) was reverse transcribed into single-stranded cDNA by use
of a Transcriptor first-strand cDNA synthesis kit (Roche Diagnostics)
according to the manufacturer’s instructions. cDNA was quantified by
real-time PCR amplification with specific primers (Table 2) by use of a
LightCycler 480 SYBR green Imaster kit and a LightCycler 480 instrument
(both from Roche Diagnostics) with an initial incubation of 95°C for 10
min, followed by 45 cycles of 10 s at 95°C, 20 s at 60°C, and 10 s at 72°C. In
all cases, the expression levels were standardized relative to the transcrip-
tion levels of rpoB (a housekeeping gene) for each isolate.
Cloning, overexpression, and protein purification. Full-length soxS,
robA, and ramA genes were amplified by PCR from genomic DNA of
EcDC64 strain with the primers listed in Table 2. A DNA fragment corre-
sponding to the robA gene was cloned into the pET-28 expression vector
(Novagen) between NdeI and XhoI restriction sites. The soxS and ramA
genes were cloned to MBP (maltose-binding protein) into the pETM-44
expression vector (modified pET-24d, EMBL-made vector by Arie Geer-
lof) betweenNcoI andHindIII restriction sites. Fusion proteins with aHis
tag at the N-terminal region were expressed in conventional E. coli strain
BL21(DE3) cells grown in LBmedium supplemented with 40g of kana-
mycin/ml. Cells were grown at 37°C until the OD600 reached 0.6. Protein
expression was induced by the addition of IPTG (isopropyl--D-thioga-
lactopyranoside; Calbiochem) to the culture, to a final concentration of
0.5 mM, followed by incubation for 5 to 6 h at 37°C. Cell cultures were
harvested by centrifugation (6,000  g, 20 min, 4°C). Cell pellets were
resuspended in 10 ml of lysis buffer (10 mM Tris-HCl [pH 8.0], 150 mM
NaCl) and sonicated in a Misonix S4000 sonicator. Bacterial lysates were
pelleted at 30,000 rpm for 1 h at 4°C in a 60Ti rotor (Beckman). The
supernatant was loaded onto a His-Trap HP 5-ml column (GE Health-
care-AmershamBiosciences) equilibrated in binding buffer (10mMTris-
HCl [pH 8.0], 5 mM imidazole, 500 mMNaCl). The target proteins were
eluted with 50 ml of elution buffer (10 mM Tris-HCl [pH 7.0], 150 mM
imidazole, 500 mM NaCl).
DNA mobility shift assays. Electrophoretic mobility shift assays
(EMSAs)were performed as previously described (2). TheDNApromoter
of the acrA gene was amplified by PCR from E. cloacae EcDC64 genomic
DNA by use of suitable oligonucleotide primers (Table 2), and the puri-
fied PCR fragment was cloned into the pGEM-T vector (Promega). The
presence of the desired promoter was confirmed by sequencing the DNA
plasmid with the T7 and SP6 primers of the pGEM-T vector. A DNA
probewas prepared by PCR amplification, with one of the primers labeled
with digoxigenin (DIG) at its 5= end and was then purified. DNA-protein
reaction mixtures (20 l) containing 25 ng of a DIG-labeled DNA probe
and SoxS, RamA, or RobA proteins were incubated for 30 min at 37°C in
EMSA buffer containing 20 mM Tris-HCl (pH 8), 50 mM KCl, 5% (vol/
vol) glycerol, 1g of bulk carrier sperm salmonDNA, 0.5mM1,4-dithio-
threitol, and 0.1 mg of bovine serum albumin per ml. DNA-protein
complexes were visualized by separation on a 5% nondenaturing poly-
acrylamide gel (40mMTris-acetate [pH8.0]) at 90V for 3 h andwere then
transferred to a Biodine B nylon membrane (Pall Gelman Laboratory).
DIG-labeled DNA-protein complexes were detected according to the
manufacturer’s protocol (Roche).
Nucleotide sequence accession codes. The GenBank accession codes
for the nucleotide sequences determined in the present study are as fol-
lows: JQ727666 for the soxS gene, JQ727667 for the robA gene, and
JQ727668 for the ramA gene.
RESULTS
Stressing compounds such as salicylate, decanoate, tetracycline,
and paraquat modify the resistance phenotype of E. cloacae. To
analyze the effect of salicylate, decanoate, tetracycline, and para-
quat on the resistance profile of E. cloacae, two clinical isolates of
E. cloacae were used: EcDC64 and Jc194. E. cloacae EcDC64 was
isolated from a patient admitted to the ICU of the A Coruña Uni-
versity Hospital (northwestern Spain). The bacterial isolate dis-
played a MDR phenotype overexpressing the AcrAB-TolC efflux
pump and lower permeability than strain Jc194 (with basal efflux
pump expression level) (33, 34).
The resistance profile to several antibiotic families known to be
good substrates for efflux pumps (such as macrolides, tetracy-
clines, or quinolones) was determined in both strains, by the stan-
dard disk diffusion method, in the presence or absence of the
different compounds studied (Table 3).
The effect of these compounds on the resistance profile of E.
cloacae was evaluated, and the results revealed that the suscepti-
bility to a number of antibiotics belonging to different antibiotic
familieswas reduced in bothwild-type (WT) strains in response to
the compounds.When the bacteria were incubated with salicylate
and paraquat, a decrease in the susceptibility to all of the antibi-
TABLE 4 Antibiotic susceptibility profilesa
Antibiotic
Susceptibility profile (inhibition zone diam [mm]) for:
E. cloacae EcDC64 E. cloacae Jc194
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ERY 0 9 0 9 10 0 10 10 0 11 10 0 0 0 8
TET 0 23 13 25 26 14 26 25 14 25 25 0 0 0 20
TEL 9 14 9 19 14 10 18 15 11 18 13 0 0 0 14
CIP 32 34 22 38 38 21 39 37 23 40 34 25 26 23 32
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a Antibiotic susceptibility profiles, expressed as diameters of the inhibition zones, were determined by the standard disk diffusion method for the bacterial isolates indicated.
Abbreviations: ERY, erythromycin; TET, tetracycline; TEL, telithromycin; CIP, ciprofloxacin; CHL, chloramphenicol. A value of “0” means that an inhibition zone around the disk
(6 mm) was not detected.
b pCR-BluntII-TOPO (pT	) is the empty cloning vector.
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otics was observed in both WT strains (Table 3). The effect of
tetracycline on antibiotic resistance of EcDC64was not clearly estab-
lishedbecauseof thehigh levelof tetracycline resistance shownby this
clinical isolate. However, this antibiotic was the strongest inducer of
resistance in E. cloacae strain Jc194. The inhibition zones were re-
duced for all antibiotics, which indicate a significant increase in the
resistance of this strain to the antibiotics.
Sodium decanoate had a modest effect on the antibiotic resis-
tance of strain Jc194. The susceptibility to all antibiotics, except
chloramphenicol, was slightly decreased. However, the resistance
profile of EcDC64 was not modified by incubation of this strain
with sodium decanoate. The intensity of the effect differed de-
pending on the type of molecule (Table 3).
Analysis of acrAB expression in the presence of different
stressing compounds. Flow cytometry assays were performed
with theWT strain Jc194, which showed a basal expression level of
the AcrAB-TolC efflux pump and a susceptible profile of resis-
tance. Fluorescence data for E. cloacae Jc194 cultures containing
the fusion acrAB promoter-GFP gene were measured in the pres-
ence of 10 mM sodium salicylate, 10 mM sodium decanoate, 4g
of tetracycline/ml, and 0.1 mMparaquat. The results obtained are
shown in Fig. 1A. All of the compounds tested induced an increase
in the fluorescence intensity, indicating that the AcrAB efflux
pump was upregulated in the presence of these compounds. The
greatest increase in fluorescence was observed when E. cloacae
strain Jc194 was incubated with tetracycline. A similar result was
obtained in response to salicylate, although the increase in inten-
sity was slightly lower. The compound that triggered the lowest
expression of acrAB was sodium decanoate (Fig. 1A). To confirm
the results of the acrAB expression levels obtained by flow cytom-
etry experiments with GFP as a reporter, real-time RT-PCR assays
were also performed. The results of the RT-PCR assayswere found
to be consistent with the flow cytometry data (Fig. 1B).
Roleof SoxS,RobA, andRamAregulatingAcrAB-TolCefflux
pump in response to different signals. The soxS, robA, and ramA
genes from EcDC64 were first amplified by high-fidelity PCR,
cloned into the pCR-BluntII-TOPO cloning vector, and finally
sequenced. Sequence analysis showed that genes soxS, robA, and
ramA from E. cloacae EcDC64, which were 327, 870, and 375 bp
long, respectively, encoded proteins containing 108, 289, and 124
amino acids, respectively. These proteins showed a high level of
similarity to their homologues in othermembers of the Enterobac-
teriaceae family. When the sequences obtained were compared to
the recently released genome of E. cloacae subsp. cloacae ATCC
13047 (GenBank accession code NC_014121), the amino acid
identities were 100% for SoxS and 99% for RamA. RobAdisplayed
97% amino acid identity with the respective homologue in E. clo-
acae subsp. cloacae ATCC 13047. Moreover, the upstream region
of these geneswas amplified by using two consecutive randomand
specific primers, as described above. Fragments of various lengths
(between 600 and 800 bp)were obtained. Analysis of the upstream
region of soxS revealed the presence of the soxR gene. Assembly of
the sequence of the entire locus revealed an organization similar to
that described for other Enterobacteriaceae, with divergently tran-
scribed soxR and soxS genes separated by an intergenic sequence of
98 bp. Amplification of the upstream region of ramA gene yielded
an amplicon of ca. 700 bp containing the partial coding region of
the romA gene.
In order to determine the different pathways activating theMDR
acrAB-mediated phenotype, mRNA was extracted from E. cloacae
Jc194 incubated in the presence of the compounds listed above, and
the expression levels of the soxS, robA, and ramA genes were mea-
sured by real-time RT-PCR (Fig. 2). The results confirmed a high
level of soxS expression under superoxide stress and showed that the
sodium decanoate activates robA expression (Fig. 2). Furthermore,
the ramAgenewasoverexpressed inE. cloacae Jc194 in thepresenceof
tetracycline and salicylate (Fig. 2). Moreover, the expression level of
marA gene was measured in the presence of salicylate and tetracy-
cline, and the results obtained confirmed a high level of expression of
marA gene by salycilate (data not shown).
Induction of acrAB by SoxS, RobA, and RamA in E. cloacae
Jc194. To determine the effect of the regulatory proteins SoxS,
FIG 1 (A) Induction of the acrAB operon measured by growing E. cloacae Jc194 containing the reporter plasmid pGFP in the presence of 10 mM sodium
salicylate (SAL), 10 mM sodium decanoate (DEC), 0.1 mM paraquat (PQ), or 4 g of tetracycline/ml (TET). The values shown are relative fluorescence units,
comparative to the control strain, Jgfp, grownwithout the compounds. The bars show the average values from triplicate assays. P
 0.05 in all cases. (B) RT-PCR
analysis of acrA and acrB gene expression in E. cloacae Jc194 in the presence of 10 mM sodium salicylate (SAL), 10 mM sodium decanoate (DEC), 0.1 mM
paraquat (PQ), or 4g of tetracycline/ml (TET). The bars show the average values for triplicate assays. The relative expression is calculated as 2CT, whereCT is
the ratio of the crossing points target value to the crossing point reference value. The target is the strain indicated, whereas the reference is E. cloacae Jc194 in all cases.
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RobA, and RamA on the expression level of acrAB, fluorescence
data of E. cloacae Jc194 cultures containing the acrAB promoter
fused to the gene encoding for GFP protein were measured and
quantified by flow cytometry.
The WT strain Jc194 harboring the recombinant plasmid
pGFP (Table 1) was used as an experimental control that showed
basal fluorescence intensity (fluorescence value 1). Each of the
genes encoding regulatory proteins was cloned under the control
of their own promoter in the pCR-BluntII-TOPO cloning vector
and introduced into the control strain Jc194 harboring the recom-
binant plasmid pGFP (Table 1) in order to measure the fluores-
cence intensity emitted when each of the regulators was overex-
pressed.
The results obtained by flow cytometry experiments showed
that the regulatory proteins SoxS, RobA, and RamA induced the
acrAB promoter, thus leading to a significant increase in fluores-
cence intensity (Fig. 3A). To confirm the results, the mRNA levels
of acrA and acrB genes were measured by RT-PCR. The results of
the RT-PCR assays are consistent with the flow cytometry data
(Fig. 3B).
Influence of SoxS, RobA, and RamA on acrAB expression in
E. cloacae EcDC64. In order to understand the role of the regula-
tory proteins SoxS, RobA and RamA in the MDR phenotype me-
diated by the AcrAB-TolC efflux pump in EcDC64 strain, soxS,
robA, and ramA genes were inactivated in the wild-type EcDC64
strain to generate mutant strains EcsoxS, EcrobA, and
EcramA. These knockout derivates were transformed with the
recombinant plasmid (pGFP) carrying the transcriptional fusion
of acrAB promoter-GFP gene. The WT EcDC64 strain was also
transformedwith pGFP to control for fluorescence intensity. Flow
cytometry assays were performed with the WT strain and the
knockout derivates harboring the pGFP recombinant plasmid,
and fluorescence data were measured and recorded to investigate
the effect of each regulator on the expression level of acrAB fromE.
cloacae EcDC64. The results obtained are shown in Fig. 4A. Inacti-
vation of the robA gene, which is constitutively expressed (3), led to a
significant reduction in the fluorescence intensity. The fluorescence
intensity emitted by EcrobA was reduced by half relative to that
observed in the WT strain EcDC64. However, when soxS and ramA
genes were inactivated, the fluorescence intensity remained almost
unchanged in comparison with that in theWT strain.
Complementation assays were performed to confirm the role
of these regulatory proteins on acrAB expression. The soxS, robA,
and ramA genes were amplified under the control of their own
promoter regions from theWTEcDC64 strain and cloned into the
pUCP24 vector (conferring resistance to gentamicin) in order to
transform strains EcsoxS, EcrobA, and EcramA, respectively.
The fluorescence activity of these cultures containing the pGFP
recombinant plasmid was measured and quantified by flow cy-
tometry. As expected, the fluorescence intensity was increased to
various degrees when the regulatory genes were expressed from a
plasmid into the knockout derivates (Fig. 4A). Real-time RT-PCR
FIG 2 RT-PCR analysis of soxS, robA, and ramA gene expression in E. cloacae
Jc194 in the presence of 10 mM sodium salicylate (SAL), 10 mM sodium
decanoate (DEC), 0.1 mM paraquat (PQ), or 4 g of tetracycline/ml (TET).
The bars show the average values for triplicate assays. The relative expression
was calculated as 2CT, where CT is the ratio of the crossing points target
value to the crossing point reference value. The target is the strain indicated,
whereas the reference is in all cases E. cloacae Jc194.
FIG 3 (A) Induction of acrAB operon due to ramA, soxS, and robA overexpression in E. cloacae Jc194 containing the reporter plasmid pGFP (see Materials and
Methods), Jgfp. The values shown are fluorescence units relative to the Jgfp control. The bars show the average values from triplicate assays. P
 0. 05 in all cases.
(B) RT-PCR analysis of acrA and acrB gene expression in E. cloacae Jc194 overexpressing ramA, soxS, and robA. The bars show the average values from triplicate
assays. Relative expression is calculated as 2CT, where CT is the ratio of the crossing points target value to the crossing point reference value. The target is
the indicated strains, whereas the reference is E. cloacae Jc194 in all cases.
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results confirmed the fluorescence data obtained by flow cytom-
etry assays (Fig. 4B).
Role of the soxS, robA, and ramA regulatory proteins on the
antimicrobial resistance profile ofE. cloacae.The resistance pro-
file to several antibiotic families known as good substrates for
efflux pumps (such as macrolides, tetracyclines, or quinolones)
was determined in both strains by the standard disk diffusion
method (Table 4). EcDC64 showed greater resistance or lower
susceptibility to the antibiotics tested than strain Jc194, which is
consistent with lower expression of AcrAB-TolC. Different ap-
proaches were used to determine the role of the regulatory pro-
teins (SoxS, RobA, and RamA) on the efflux-mediated resistance
profile.
First, the genes encoding regulatory proteins were overex-
pressed in E. cloacae isolate Jc194. The strains overexpressing soxS,
robA, and ramA became resistant to erythromycin, tetracycline,
and telithromycin and showed lower susceptibility to ciprofloxa-
cin. The clinical isolate Jc194 was resistant to chloramphenicol
when soxS and robAwere overexpressed and showed reduced sus-
ceptibility to this antibiotic as a result of ramA overexpression.
The strain harboring the empty cloning vector showed no signif-
icant changes in the resistance profile relative to the WT strain
(Table 4).
On the other hand, the lack of the regulatory protein SoxS led
to an increase in susceptibility to all antibiotics tested, except for
chloramphenicol, where the inhibition zone determined by disk
diffusion test remained unchanged relative to that observed for
the WT strain. The MDR phenotype of isolate EcDC64 was re-
stored or even increased for all antibiotics tested, except for tetra-
cycline. The overexpression of soxS in EcsoxS led to partial res-
toration of the resistance to tetracycline by EcsoxS.
The same trend was observed in the isogenic EcrobA and
EcramA isolates. The lack of RobA and RamA proteins had a
similar effect on the resistance of EcDC64 isolate, with some ex-
ceptions (Table 4). For some antibiotics, such as tetracycline and
ciprofloxacin, the increase in susceptibility was greater than that
observed for EcsoxS. Analysis of knockout isogenic derivates
EcrobA and EcramA overexpressing the robA and ramA genes,
respectively, showed that the resistance profile was similar to that
of the EcDC64 clinical isolate, although the MDR phenotype was
not fully restored, as also observed in EcsoxS. Interestingly, the
knockout derivates EcsoxS, EcrobA and EcramA containing
the expression vector pUCP24 without any insertion were slightly
more susceptible to the antibiotics than the other knockout deri-
vates (Table 4). Moreover, susceptibility testing was performed
with WT strains Jc194 and EcDC64 and the knockout derivates
fromEcDC64 (Table 3) in order to evaluate the effect of the lack of
each regulator on the resistance profile in the presence of stressing
agents.
In general, EcsoxS showed increased antibiotic resistance in
response to the presence of salicylate, sodium decanoate and tet-
racycline. However, the superoxide stress generated by paraquat
did not stimulate an increase in the resistance in soxS defective
strain EcDC64. The antibiotic susceptibility also increased when
EcsoxS was incubated with paraquat (Table 3). The concentra-
tion used in this case was 50 M, which allowed the growth of
EcsoxS and susceptibility testing to be performed. Analysis of
antibiotic resistance profile of EcrobA mutant revealed that so-
dium decanoate, unlike salicylate, paraquat, and tetracycline, was
not able to induce an increase in the antibiotic resistance of the
robA defective EcDC64 clinical isolate.
Finally, tetracycline only induced an increase in the resistance
to erythromycin by the isogenic knockout EcramA. Susceptibil-
ity to tetracycline was almost unchanged and increased suscepti-
bility to telithromycin, ciprofloxacin and chloramphenicol was
observed (Table 3). Although salicylate also induces overexpres-
sion of ramA, EcramA showed an increased antibiotic resistance
in response to salicylate, due to the presence of a functional MarA
regulator.
SoxS, RobA, and RamA bind to upstream region of acrA
gene. The aforementioned results indicate that SoxS, RobA, and
RamAactivators play amajor role in inducing acrAB expression in
response to the presence of compounds such as salicylate, super-
oxides, decanoate, or antibiotics such as tetracycline. To under-
FIG 4 (A) Level of expression of acrAB in knockout strains from E. cloacae EcDC64 and their complemented strains. The values shown are fluorescence units
relative to the EcDC64WTstrain containing the reporter plasmid, pGFP. The bars show the average values from triplicate assays. *,P
 0.05. (B)RT-PCRanalysis
of acrA and acrB gene expression in knockout strains from E. cloacae EcDC64 and their complemented strains. The bars show the average values from triplicate
assays. The relative expression is calculated as 2CT, where CT is the ratio of the crossing points target value to the crossing point reference value. The target
is the indicated strains, whereas the reference is E. cloacae EcDC64 in all cases.
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stand the regulation of acrAB by these regulatory proteins, EMSAs
with SoxS, RobA, and RamA were performed. Plasmids encoding
the histidine-tagged proteins were constructed as described in
Materials and Methods. SoxS and RamA proteins were purified
after being fused to MBP (maltose-binding protein) to enhance
their solubility. The MBP was also purified for use as a control.
The upstream region of acrA gene was amplified by PCR, and the
fragment was incubated with each of the proteins. The three pro-
teins—SoxS, RobA, and RamA—from the E. cloacae EcDC64 iso-
late bound to the promoter of the acrA gene, as revealed by the
shift in the gel migration, whereas MBP did not bind to the pro-
moter (Fig. 5).
DISCUSSION
Multidrug efflux pumps are the major agents conferring drug re-
sistance in bacteria. Several investigators have studied the impor-
tant roles of the AcrAB-TolC efflux pump in bacterial drug resis-
tance and virulence in Enterobacteriaceae (28, 35). The data
currently available in E. coli and other Enterobacteriaceae show
that multidrug efflux pumps are often expressed under precise
and elaborate transcriptional control, including specific regula-
tors such as AcrR, and global regulators such as MarA, SoxS, and
Rob. In E. coli, the transcriptional activators belonging to the
AraC/XylS family interact with AcrAB and effectively enhance ef-
flux (15). Because theAcrAB-TolCplays a predominant role in the
intrinsic resistance ofE. cloacae to awide range of antibiotics, dyes,
detergents, and solvents, as well as in bacterial fitness and viru-
lence (33, 34), study of its regulation is of great importance in
understanding the action of antibiotics and bactericidal agents in
E. cloacae and related organisms. The mar, sox, and rob regulons
are well-characterized regulatory systems in E. coli (4, 21, 31, 51).
It is thought that the influx and efflux in E. cloacae might be reg-
ulated in a similar way as in E. coli. Genomic analysis of E. cloacae
EcDC64 revealed the presence of SoxS and RobA regulators, es-
sentially identical to those in E. coli. The ramA regulon was found
to show the same genetic organization as that observed in Citro-
bacter (41) and Klebsiella (5) species, in which the ramA locus is
composed by romA and ramA genes, both controlled by the RamR
repressor. The DNA-binding domains of SoxS, RobA, and RamA
proteins from EcDC64 share a high level of sequence identity,
which suggests that these proteins have overlapping specificity.
These regulators activate the transcription of a large set of pro-
moters, including the promoter of acrAB, through the direct bind-
ing to a degenerated and asymmetrical DNA sequence, known as
the marbox sequence (24, 27). Analysis of the upstream region of
the acrAB operon of E. cloacae (of both clinical isolates used in the
present study) revealed a marbox sequence in a suitable position.
The results presented here demonstrate the importance of SoxS,
RobA, and RamA regulators in the modulation of AcrAB-TolC-
mediated antibiotic resistance in E. cloacae.
Functional genomics approaches such as knockout studies or
heterologous expression studies have been used to assess the effect
of these transcriptional activators on acrAB expression. The soxS,
robA, and ramA knockout strains derived from MDR E. cloacae
EcDC64 were constructed. The soxS, robA, and ramA genes were
also cloned into plasmids and overexpressed in the susceptible
strain E. cloacae Jc194 under the control of their own promoter
regions. The expression level of acrAB was measured by two dif-
ferent methods: flow cytometry using the acrAB promoter-GFP
gene fusion as a reporter and real-time RT-PCR. In addition, sus-
ceptibility testing was performed with all of the different strains
obtained (in which soxS, robA, and ramA were inactivated and
overexpressed). Transcriptional activation of acrAB is the pre-
dominant cause ofmultidrug resistance in strains that overexpress
MarA or the closely related global regulators SoxS, RobA, and
RamA (6, 9, 12, 19, 20, 22, 32, 40, 43, 47, 51, 52). Chollet et al. (9)
have described how an increase in ramA-mediated acrAB expres-
sion leads to an increase in resistance to tetracycline, chloram-
phenicol, quinolones, and -lactams in E. aerogenes. In the same
way, Hornsey et al. (17) described the emergence of AcrAB-medi-
ated tigecycline resistance in E. cloacae through the RamA regula-
tor. Our findings demonstrated that increased levels of soxS, robA,
and ramA transcription activated acrAB expression, which led to
an increase in antibiotic resistance in E. cloacae Jc194. The data
indicated a correlation between the increased resistance to mac-
rolides, tetracycline, ketolides, fluoroquinolones, and chloram-
phenicol and the expression levels of acrAB and soxS, robA, and
ramA. The results of DNAmobility shift assays indicated that each
of these three proteins directly control the expression of acrAB
through binding to its upstream promoter region. Overall, the
data indicated that SoxS, RobA, and RamA activators play amajor
role as activators of AcrAB-TolC expression. Overexpression of
ramA caused the highest acrAB gene expression, followed by over-
expression of SoxS and, to a lesser extent, RobA.
The differences in the acrAB expression levels were also illus-
trated by quinolone resistance in Jc194. The effects of RobA were
generally weaker than those of RamA and SoxS for both antibiotic
resistance and gene expression. In contrast to SoxS and RamA,
RobA expression is constitutive (46), and it is inactive until acti-
vated by an induction signal (40, 42), which may explain the
greater effect of the overexpressed soxS and ramA genes in the
activation of the AcrAB-TolC efflux pump. On the other hand,
the inactivation of the regulatory genes soxS, robA, and ramA in E.
cloacae ECDC64 led to increased susceptibility to all antibiotics
tested, except for chloramphenicol, in comparison to that of the
WT strain, showing that the knockout acquires a similar antibiotic
resistance profile to drug-susceptible strain Jc194. However, only
inactivation of the robA gene had a slight effect on acrAB expres-
FIG5 Electrophoreticmobility of theDNA fragments containing the EcDC64
upstream region of acrA gene from E. cloacae EcDC64. Lane 1, DIG-labeled
DNA probe; lane 2, DIG-labeled DNA probe and SoxS protein fused to MBP;
lane 3, DIG-labeled DNA probe and RobA protein; lane 4, DIG-labeled DNA
probe and RamA protein fused to MBP; lane 5, DIG-labeled DNA probe and
MBP protein.
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sion, which was reduced by half. These data, supported by the
results obtained in the susceptibility analysis, suggest that RobA
plays an important role in the antibiotic resistance of E. cloacae
EcDC64. Although the inactivation of soxS and ramA did not af-
fect the expression of acrAB, these proteins also affected the anti-
biotic resistance of isolate EcDC64. This may be due to the level of
expression of soxS and ramA genes, which was significantly lower
than that of the robA gene. Therefore, the effect of the inactivation
of soxS and ramA on acrAB expression goes unnoticedwhenRobA
is functional. In addition, these regulatory proteins control many
other genes involved in antimicrobial resistance, which may ex-
plain the AcrAB-independent modification in the resistance pro-
file of EcDC64 (27).
In E. coli, AcrAB-TolC is upregulated in response to different
signals, such as aromaticweak acids (salicylate), superoxides (gen-
erated by paraquat), bile salts, fatty acids (decanoate), and tetra-
cycline (49). These toxic compounds activate the transcription of
global regulators, and they cause upregulation of the AcrAB-TolC
efflux pump (11, 40, 45, 48). In the present study, we examined
whether a similar mechanism occurs in E. cloacae. Indeed, the
AcrAB-TolC system was upregulated by salicylate, decanoate,
paraquat, and tetracycline, which affected the resistance profile of
E. cloacae, as observed by a decreased susceptibility to a number of
antibiotics. The results demonstrated that the induction profiles
in E. cloacae are very similar to the induction profiles previously
described in other species belonging to the Enterobacteriaceae
family. The increased expression of acrABwas significantly corre-
lated with the degree of resistance shown by E. cloacae Jc194 to
different antibiotics, with some exceptions. Induction with tetra-
cycline triggered the largest increase in resistance to all antibiotics
tested. The lowest effect was observed after incubation of strain
Jc194 with decanoate. The resistance to chloramphenicol was not
modified in response to this compound. The increased levels of
resistance to erythromycin, telithromycin, and ciprofloxacin,
whichwere shownby Jc194 in response to salicylate, paraquat, and
tetracycline, were similar, although the tetracycline had a greater
effect on tetracycline and chloramphenicol resistance. Bacteria
must distinguish amongdifferent stress conditions and respond in
an appropriate manner. Each activator is regulated in response to
a different signal, causing the final induction of acrAB. As de-
scribed above, the AcrAB-TolC efflux pump in E. cloacae is up-
regulated by SoxS, RobA, and RamA, causing an efflux-mediated
MDR phenotype in E. cloacae. The present data revealed that
acrAB from E. cloacae is activated through different pathways de-
pending on the stimulus applied. Salicylate induced ramA expres-
sion, in addition to activating marA transcription, as previously
described in E. coli (45). soxS and robA expression was also mod-
erately increased by salicylate in E. cloacae, unlike in Salmonella, in
which robA is downregulated (16). The expression data supported
by the susceptibility testing results suggest that salicylate induces
activation of the AcrAB-TolC efflux pump, mainly through the
MarA regulator. In E. coli, tetracycline induces marA, soxS, and
robA expression, although the intensity of the effect differs (48).
Tetracycline-mediated similar adaptation mechanisms of in-
creased efflux in E. cloacae but, unlike E. coli, it activated ramA
expression instead of marA. The effect of tetracycline on ramA
expression was greater than the effect on soxS and robA expres-
sion, suggesting that the RamA activator plays a key role in the
AcrAB regulation network. This hypothesis was supported by the
antibiotic resistance profile shown by the ramA-defective E. cloa-
cae EcDC64 isolate, in which antibiotic resistance was not induced
by tetracycline. Furthermore, E. cloacae showed an oxidative stress
response similar to that described in E. coli, in which soxS is highly
overexpressed and robA is downregulated by paraquat (29), show-
ing an increased resistance profile. However, paraquat increased
the antibiotic susceptibility of soxS-defective E. cloacae EcDC64,
which confirms the involvement of SoxS in the regulation of
AcrAB under oxidative stress conditions. Rosenberg et al. (40)
found that the induction of acrAB by decanoate requires Rob, but
not MarA or SoxS, in E. coli.However, decanoate downregulated
robA transcription and activated marA expression in Salmonella
enterica serovar Typhimurium (16). We found a model for the
acrAB regulatory network in E. cloacae similar to that in E. coli.
Decanoate was not able to induce an increase in the antibiotic
resistance of robA-defective EcDC64. Moreover, only RobA was
upregulated by decanoate, which suggests that it mediates the reg-
ulation of AcrAB by free fatty acids such as decanoate, and it ap-
parently helps the survival ofE. cloacae bymaking itmore resistant
to antimicrobial agents.
In summary, the results presented here show that the AraC/
XylS regulators SoxS, RobA, and RamA play an important role in
efflux-mediated multidrug resistance in E. cloacae by increasing
acrAB expression. It was further demonstrated that each activator
is regulated in response to a different signal, causing the final in-
duction of acrAB. Therefore, the AcrAB-TolC efflux pump in E.
cloacae is activated through different pathways depending on the
stimulus applied, thus conferring resistance to a variety of antimi-
crobial agents.
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